28.77
price up icon0.35%   0.10
after-market アフターアワーズ: 28.95 0.18 +0.63%
loading
前日終値:
$28.67
開ける:
$28.68
24時間の取引高:
821.53K
Relative Volume:
1.38
時価総額:
$2.06B
収益:
$81.26M
当期純損益:
$-102.66M
株価収益率:
-21.03
EPS:
-1.3678
ネットキャッシュフロー:
$-77.62M
1週間 パフォーマンス:
+13.67%
1か月 パフォーマンス:
+25.85%
6か月 パフォーマンス:
+21.75%
1年 パフォーマンス:
+90.53%
1日の値動き範囲:
Value
$27.01
$28.83
1週間の範囲:
Value
$25.31
$28.83
52週間の値動き範囲:
Value
$13.60
$29.75

Zymeworks Inc. Stock (ZYME) Company Profile

Name
名前
Zymeworks Inc.
Name
セクター
Healthcare (1033)
Name
電話
604-678-1388
Name
住所
1385 West 8th Avenue, Suite 540, Vancouver, BC
Name
職員
170
Name
Twitter
@ZymeworksInc
Name
次回の収益日
2026-08-06
Name
最新のSEC提出書
Name
ZYME's Discussions on Twitter

Compare ZYME vs VRTX, REGN, ARGX, MRNA, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
ZYME icon
ZYME
Zymeworks Inc.
28.77 1.90B 81.26M -102.66M -77.62M -1.3678
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
547.59 136.93B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
828.50 85.11B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
1,011.11 64.95B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
138.89 53.23B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
211.58 45.38B 742.00K -1.37B -1.07B -7.0731

Zymeworks Inc. Stock (ZYME) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-12 アップグレード Wells Fargo Equal Weight → Overweight
2025-12-03 開始されました Citizens JMP Mkt Outperform
2025-10-24 再開されました Wells Fargo Equal Weight
2025-10-14 アップグレード H.C. Wainwright Neutral → Buy
2025-10-10 開始されました B. Riley Securities Buy
2025-05-20 開始されました TD Cowen Buy
2024-12-16 アップグレード JP Morgan Neutral → Overweight
2024-11-07 アップグレード Leerink Partners Market Perform → Outperform
2024-11-01 ダウングレード Wells Fargo Overweight → Equal Weight
2023-03-21 再開されました Wells Fargo Overweight
2023-01-04 繰り返されました H.C. Wainwright Neutral
2022-12-20 アップグレード Jefferies Hold → Buy
2022-11-01 ダウングレード H.C. Wainwright Buy → Neutral
2022-10-21 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-10-04 再開されました Wells Fargo Overweight
2022-05-05 アップグレード Guggenheim Neutral → Buy
2022-03-15 開始されました Evercore ISI Outperform
2021-12-10 アップグレード SVB Leerink Mkt Perform → Outperform
2021-11-17 再開されました Guggenheim Neutral
2021-10-07 開始されました Jefferies Hold
2021-03-31 開始されました Credit Suisse Outperform
2021-02-25 ダウングレード SVB Leerink Outperform → Mkt Perform
2021-02-08 再開されました H.C. Wainwright Buy
2021-01-25 ダウングレード Citigroup Buy → Neutral
2020-09-29 再開されました JP Morgan Neutral
2020-08-06 開始されました SVB Leerink Outperform
2020-01-10 開始されました Wolfe Research Outperform
2019-12-09 開始されました JP Morgan Neutral
2019-11-25 開始されました H.C. Wainwright Buy
2019-11-20 開始されました Guggenheim Buy
2019-09-30 アップグレード Raymond James Outperform → Strong Buy
2019-08-30 開始されました Stifel Buy
2019-07-18 開始されました Deutsche Bank Buy
2018-05-11 アップグレード Barclays Underweight → Equal Weight
2018-03-19 開始されました Raymond James Outperform
すべてを表示

Zymeworks Inc. (ZYME) 最新ニュース

pulisher
Aug 21, 2026

Theravance (NASDAQ: TBPH) sets vote on cash buyout with ampreloxetine CVR upside - Stock Titan

Aug 21, 2026
pulisher
Aug 18, 2026

Enterprise value to revenue forward of Zymeworks Inc. – SWB:ZA8 - TradingView

Aug 18, 2026
pulisher
Aug 18, 2026

Zymeworks (ZYME) Session Brief: Climbs 2.69% to $25.99 in the Latest Session; Reference Levels: $24.69 and $27.29 Define the Nearby Reference Levels at the ClosePCR Spike - vinanet.vn

Aug 18, 2026
pulisher
Aug 17, 2026

How Zymeworks’ Bigger Loss, Buyback and Milestones Pivot At Zymeworks (ZYME) Has Changed Its Investment Story - simplywall.st

Aug 17, 2026
pulisher
Aug 15, 2026

ZYME Q2 2026 Earnings: Wider-than-Expected Loss of -$0.62 per Share Reflects Clinical-Stage InvestmentProduct Revenue Analysis - vinanet.vn

Aug 15, 2026
pulisher
Aug 12, 2026

Zymeworks Inc. (ZYME) stock price, news, quote and history - Yahoo Finance Australia

Aug 12, 2026
pulisher
Aug 12, 2026

Q3 Earnings Estimate for Zymeworks Issued By HC Wainwright - MarketBeat

Aug 12, 2026
pulisher
Aug 11, 2026

Zymeworks Inc. (ZYME) Stock Price, News, Quote & History - Yahoo! Finance Canada

Aug 11, 2026
pulisher
Aug 11, 2026

TBPH Meets Q2 Earnings Estimates, to be Acquired by Zymeworks - Yahoo Finance

Aug 11, 2026
pulisher
Aug 11, 2026

HC Wainwright Issues Negative Outlook for Zymeworks Earnings - MarketBeat

Aug 11, 2026
pulisher
Aug 11, 2026

Zymeworks Announces Participation in Upcoming Investor Conferences - Macau Business

Aug 11, 2026
pulisher
Aug 11, 2026

Zymeworks Inc. to Participate in Upcoming Investor Conferences in September - Quiver Quantitative

Aug 11, 2026
pulisher
Aug 10, 2026

Theravance Biopharma, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update - TradingView

Aug 10, 2026
pulisher
Aug 10, 2026

Theravance's Once-Daily COPD Treatment Posts $70.7M Sales - Stock Titan

Aug 10, 2026
pulisher
Aug 09, 2026

Zymeworks (ZYME) Is Up 7.3% After Q2 Swing Back to Net LossesWhat's Changed - simplywall.st

Aug 09, 2026
pulisher
Aug 09, 2026

Assenagon Asset Management S.A. Has $32.73 Million Stake in Zymeworks Inc. $ZYME - MarketBeat

Aug 09, 2026
pulisher
Aug 08, 2026

Zymeworks Inc reports results for the quarter ended March 31Earnings Summary - TradingView

Aug 08, 2026
pulisher
Aug 08, 2026

Zymeworks (ZYME) Stock Rich Valuation Meets Widening Losses - Sahm

Aug 08, 2026
pulisher
Aug 07, 2026

Zymeworks Inc (ZYME) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 07, 2026
pulisher
Aug 07, 2026

What is HC Wainwright's Forecast for Zymeworks Q2 Earnings? - MarketBeat

Aug 07, 2026
pulisher
Aug 07, 2026

Zymeworks Inc. (ZYME): Analyst Consensus and Potential 72% Upside Make This Biotech Stock Worth Watching - DirectorsTalk Interviews

Aug 07, 2026
pulisher
Aug 07, 2026

Is Zymeworks Inc (ZYME) Facing Challenges After Q2 Earnings Miss? GF Score: 65/100, Revenue at $4.6M - GuruFocus

Aug 07, 2026
pulisher
Aug 07, 2026

Zymeworks Inc. Stock 12‑Month Price Target Raised to $40, Implies 73% Upside - TradingView

Aug 07, 2026
pulisher
Aug 06, 2026

Zymeworks Inc. (ZYME) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance

Aug 06, 2026
pulisher
Aug 06, 2026

Zymeworks Inc. reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Zymeworks Inc. Q2 2026: Revenue $4.6M, EPS $(0.62) — 10-Q Summary - TradingView

Aug 06, 2026
pulisher
Aug 06, 2026

Zymeworks Provides Corporate Update and Reports Second Quarter 2026 Financial Results - The Manila Times

Aug 06, 2026
pulisher
Aug 06, 2026

Zymeworks Inc. (NASDAQ: ZYME) details $250M royalty deal and Theravance bid - Stock Titan

Aug 06, 2026
pulisher
Aug 06, 2026

Tranche Update on Zymeworks Inc.'s Equity Buyback Plan announced on May 14, 2026. - marketscreener.com

Aug 06, 2026
pulisher
Aug 06, 2026

Zymeworks under pressure as earnings arrive amid acquisition By Investing.com - Investing.com Nigeria

Aug 06, 2026
pulisher
Aug 06, 2026

What is HC Wainwright's Estimate for Zymeworks Q3 Earnings? - MarketBeat

Aug 06, 2026
pulisher
Aug 06, 2026

Segall Bryant & Hamill LLC Takes Position in Zymeworks Inc. $ZYME - marketbeat.com

Aug 06, 2026
pulisher
Aug 06, 2026

Earnings Flash (ZYME) Zymeworks Inc. Reports Q2 Revenue $4.6M - marketscreener.com

Aug 06, 2026
pulisher
Aug 05, 2026

Zymeworks Inc. to Pursue Additional Strategic Acquisitions - marketscreener.com

Aug 05, 2026
pulisher
Aug 05, 2026

A Post Acquisition Look At Zymeworks (NASDAQ:ZYME) - Seeking Alpha

Aug 05, 2026
pulisher
Aug 04, 2026

Zymeworks Inc. expected to post a loss of 46 cents a shareEarnings Preview - TradingView

Aug 04, 2026
pulisher
Aug 03, 2026

ZYME|Zymeworks Inc|Price:22.598|Chg%:+0.787 - TradingKey

Aug 03, 2026
pulisher
Aug 02, 2026

Perceptive Advisors LLC Increases Stock Holdings in Zymeworks Inc. $ZYME - MarketBeat

Aug 02, 2026
pulisher
Aug 02, 2026

Zymeworks (ZYME) Slips 3.4% to $21.94 as Biotech Sector Faces Renewed VolatilityPut Flow Alert - vinanet.vn

Aug 02, 2026
pulisher
Aug 01, 2026

Zymeworks (ZYME) Slides 3.4% to $21.94 as Support Level Comes into FocusIntraday Profile - Vinanet

Aug 01, 2026
pulisher
Jul 31, 2026

Zymeworks Inc. Revenue Breakdown – NASDAQ:ZYME - TradingView

Jul 31, 2026
pulisher
Jul 31, 2026

Zymeworks Inc. (ZYME) - DirectorsTalk Interviews

Jul 31, 2026
pulisher
Jul 28, 2026

Rubric Capital Management LP Acquires 1,250,000 Shares of Zymeworks Inc. $ZYME - MarketBeat

Jul 28, 2026
pulisher
Jul 28, 2026

Zymeworks Inc (ZYME) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 28, 2026
pulisher
Jul 27, 2026

Zymeworks Inc (ZYME) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

SummitTX Capital L.P. Purchases 97,159 Shares of Zymeworks Inc. $ZYME - MarketBeat

Jul 27, 2026
pulisher
Jul 27, 2026

Zymeworks Inc (ZYME) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Zymeworks Inc (ZYME) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Zymeworks Inc (ZYME) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Zymeworks Inc (ZYME) Balance Sheet - tradingkey.com

Jul 26, 2026
pulisher
Jul 26, 2026

Zymeworks Inc (ZYME) Cash Flow - TradingKey

Jul 26, 2026

Zymeworks Inc. (ZYME) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$123.98
price up icon 0.00%
$61.33
price up icon 0.03%
$112.82
price down icon 3.22%
$236.01
price down icon 0.09%
ONC ONC
$371.98
price down icon 0.66%
$211.58
price up icon 1.01%
大文字化:     |  ボリューム (24 時間):